A clinical trial to study the effects of levamisole in children with steroid sensitive nephrotic syndrome
Phase 3
- Conditions
- Health Condition 1: null- Frequently relapsing steroid sensitive nephrotic syndrome with or without steroid dependence
- Registration Number
- CTRI/2009/091/000116
- Lead Sponsor
- Emma Childrens Hospital AMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Frequently relapsing steroid sensitive nephrotic syndrome with or without steroid dependence
Age <18 years
Written informed consent
Exclusion Criteria
Previous treatment with levamisole, cyclosporine or mycophenolate mofetil
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method